Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Ocumension Therapeutics ( (HK:1477) ).
Ocumension Therapeutics has announced proposed amendments to its existing memorandum and articles of association, aiming to adopt a new version that supports the expansion of a paperless listing regime and the introduction of a new treasury shares regime. These changes are intended to optimize the company’s operations in line with recent consultations by the Stock Exchange of Hong Kong, pending shareholder approval at the upcoming annual general meeting.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, primarily involved in the healthcare industry, focusing on therapeutic solutions.
YTD Price Performance: 10.67%
Average Trading Volume: 2,325,112
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.09B
For a thorough assessment of 1477 stock, go to TipRanks’ Stock Analysis page.